2018
DOI: 10.1093/heapol/czy076
|View full text |Cite
|
Sign up to set email alerts
|

The availability, price and affordability of antidiabetic drugs in Hubei province, China

Abstract: Based on the high prevalence and undiagnosed rate of diabetes mellitus in China in recent years, the aim of this work was to evaluate the availability, price and affordability of pharmacotherapy for diabetes in public hospitals in Hubei province, China. In 2016, a cross-sectional survey was conducted using World Health Organization/Health Action International (WHO/HAI) methodology. Information on the availability and prices of 20 antidiabetic drugs was collected from 34 public hospitals representing three leve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
30
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(34 citation statements)
references
References 17 publications
4
30
0
Order By: Relevance
“…Similar results (0.74) were reported in a previous study that was conducted in rural areas in China . It is worth mentioning that previous studies from China reported that MPRs of simvastatin, diclofenac, loratadine, amlodipine, metformin, and omeprazole (OB) substantially exceeded the warning line . These medicines were also found to have high prices in this study.…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…Similar results (0.74) were reported in a previous study that was conducted in rural areas in China . It is worth mentioning that previous studies from China reported that MPRs of simvastatin, diclofenac, loratadine, amlodipine, metformin, and omeprazole (OB) substantially exceeded the warning line . These medicines were also found to have high prices in this study.…”
Section: Discussionsupporting
confidence: 90%
“…14 It is worth mentioning that previous studies from China reported that MPRs of simvastatin, diclofenac, loratadine, amlodipine, metformin, and omeprazole (OB) substantially exceeded the warning line. 13,17,18 These medicines were also found to have high prices in this study. This might be related to insufficient competitiveness caused by too few manufacturers for long periods of time.…”
Section: Discussionsupporting
confidence: 55%
See 1 more Smart Citation
“…Most surveys focused on the essential medicines for adults [24,25,26,27,28] and children [29,30,31,32]. Some others focused on medicines for cardiovascular patients [33,34], antidiabetics [35,36], and orphans [37,38]. A few studies have been conducted to evaluate the cost, availability, and affordability of anticancer medicines [39,40,41], but did not cover China.…”
Section: Introductionmentioning
confidence: 99%
“…Policymakers could improve future policies using current evidence to ensure the same availability of antidiabetic drugs at all hospitals as well as their rational use by health care providers and patients. [43]…”
Section: Discussionmentioning
confidence: 99%